Coronavirus: WHO testing three new drugs to treat Covid-19

The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for Covid-19 patients.“These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised Covid-19 patients,” it said in a statement on the Solidarity Plus trial.The trial involves thousands of researchers at more than 600 hospitals, WHO Director…

Read the original article at South China Morning Post